Smith & Nephew SNATS Inc (SNN) — Technical state
As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 57 out of 100 (momentum 39 · quality 56 · valuation 70), as of 2026-11-03.
- Signal: Recovery attempt under the 200-day — Trades +6.9% vs the 50-day and -2.2% vs the 200-day average, 17.2% below the 52-week high and +16% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
- Trend: Smith & Nephew SNATS Inc trades 6.9% above its 50-day and 2.2% below its 200-day moving average. (as of 2026-11-02)
Smith & Nephew designs and sells medical devices across three areas: joint replacement and trauma implants, sports-medicine tools for minimally invasive joint surgery, and wound-care products for chronic and post-operative wounds. It supplies hospitals and surgeons in the UK, the US and other markets, and is headquartered in Watford, England.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the SNN overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +6.9% vs the 50-day and -2.2% vs the 200-day average, 17.2% below the 52-week high and +16% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+4.3%
- vs 50-day+6.9%
- vs 200-day-2.2%
- 52-week band17.2% off the high · +16% off the low
- Streak1 consecutive up session
- 50-day crossprice crossed up through the 50-day 12 sessions ago
- Stochastic%K 73.1 · %D 70.9 · bull cross
Continue: the SNN chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-02
Quick answers
What is the current Closelooknet signal on SNN?
Recovery attempt under the 200-day — Trades +6.9% vs the 50-day and -2.2% vs the 200-day average, 17.2% below the 52-week high and +16% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is SNN above its 50-day and 200-day moving averages?
As of 2026-11-02, Smith & Nephew SNATS Inc trades +6.9% above its 50-day and -2.2% below its 200-day average, with the 20-day +4.3% away.
How far is SNN from its 52-week high?
17.2% below the 52-week high and 16% above the 52-week low, as of 2026-11-02.
Related in the Closelooknet universe
then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- DXCM DexCom Incindustry
- SECT-B.ST Sectra AB (publ)industry
- GMED Globus Medicalindustry
- CEVI.ST CellaVision ABindustry
- SOON.SW Sonova H Agindustry
- SYK Stryker Corporationindustry
- PACB Pacific Biosciences of Californiaindustry
- QSI QuantumSi Incindustry
- MED.SW Medartis Holding AGindustry
- AXGN Axogen Incindustry
- DEMANT.CO Demant A/Sindustry
- IRTC iRhythm Technologies Incindustry
- 300760.SHE Shenzhen Mindray Bio-Medical Electronics Co Ltd Class Aindustry
- HAE Haemonetics Corporationindustry
- MDT Medtronic PLCindustry
- PHG Koninklijke Philips NV ADRindustry
- CBLL CeriBell, Incindustry
- STE STERIS plcindustry
- ABT Abbott Laboratoriesindustry
- EW Edwards Lifesciences Corpindustry